Related Experiment Video
Updated: Mar 19, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
The proteome of schizophrenia
Juliana M Nascimento1, Daniel Martins-de-Souza2
1Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, Sao Paulo, Brazil; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.
Proteomics reveals complex molecular underpinnings of schizophrenia, identifying potential biomarkers and therapeutic targets. This research reviews recent proteomic studies on brain and blood samples from schizophrenia patients.
Area of Science:
- Neuroscience
- Molecular Biology
- Psychiatry
Background:
- Schizophrenia is a complex disorder influenced by genetic and environmental factors affecting brain function.
- Cellular dysfunction is increasingly recognized as a key factor in schizophrenia pathogenesis.
- Proteomics offers insights into the biochemical basis of schizophrenia at cellular and tissue levels.
Purpose of the Study:
- To review proteomic investigations of schizophrenia over the last five years.
- To identify differentially expressed proteins and biochemical pathways involved in schizophrenia.
- To highlight potential protein biomarkers for diagnosis, prognosis, and treatment monitoring.
Main Methods:
- Analysis of postmortem brain tissue from schizophrenia patients.
- Proteomic analysis of peripheral blood serum and plasma from schizophrenia patients.
- Mass spectrometry-based proteomics for protein identification and quantification.
Main Results:
- Identification of specific proteins and pathways dysregulated in schizophrenia.
- Discovery of potential protein biomarkers in both central nervous system and peripheral tissues.
- Integration of proteomic data to understand schizophrenia pathobiology.
Conclusions:
- Proteomics provides a comprehensive view of schizophrenia's biochemical systems.
- Identified proteins show promise as diagnostic and prognostic biomarkers.
- Proteomic findings suggest novel therapeutic targets for schizophrenia treatment.
Related Concept Videos
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Schizophrenia
Psychological and Sociocultural Causes of Schizophrenia
Positive Symptoms of Schizophrenia: Hallucinations and Delusions
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...

